Analyst Predicts Positive Outlook for Adverum Biotechnologies with Increased Price Target
On February 6, 2024, Graig Suvannavejh, an analyst at Mizuho, expressed his positive outlook on Adverum Biotechnologies (NASDAQ:ADVM) by maintaining ...
On February 6, 2024, Graig Suvannavejh, an analyst at Mizuho, expressed his positive outlook on Adverum Biotechnologies (NASDAQ:ADVM) by maintaining ...
Adverum Biotechnologies Witnesses a Significant Decrease in Short Interest Date: July 20, 2023 Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage biotechnology ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.